Welcome to LookChem.com Sign In|Join Free
  • or
3-(4-bromo-phenyl)-cyclopent-2-enone is a chemical compound characterized by its molecular formula C11H9BrO, which indicates the presence of 11 carbon atoms, 9 hydrogen atoms, 1 bromine atom, and 1 oxygen atom. 3-(4-bromo-phenyl)-cyclopent-2-enone features a cyclopentene ring, which is a five-membered carbon ring with a double bond, and a phenyl group (a benzene ring) substituted at the 4-position with a bromine atom. The bromine atom adds significant reactivity and molecular weight to the compound, which can be utilized in various chemical reactions and applications. The structure of 3-(4-bromo-phenyl)-cyclopent-2-enone provides a unique combination of aromatic and cyclic characteristics, making it a potentially valuable intermediate in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.

2108-55-6

Post Buying Request

2108-55-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2108-55-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2108-55-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,0 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2108-55:
(6*2)+(5*1)+(4*0)+(3*8)+(2*5)+(1*5)=56
56 % 10 = 6
So 2108-55-6 is a valid CAS Registry Number.

2108-55-6Downstream Products

2108-55-6Relevant academic research and scientific papers

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

-

Page/Page column 29-30, (2010/02/14)

Alkyne compounds of formula I wherein A, B, W, X, Y, Z, R1, and R2 have the meanings given herein, which have MCH-receptor antagonistic activity and are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.

NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS

-

Page/Page column 79, (2010/02/14)

The invention relates to alkyne compounds of general formula (I), wherein the groups and radicals A, B, W, X, Y, Z, R1, and R2 have the meanings indicated in claim 1. The invention further relates to medicaments containing at least one inventive alkyne. The disclosed medicaments are suitable for the treatment of metabolic disorders and/or eating disorders, particularly adiposity and diabetes, as a result of the MCH receptor antagonistic activity thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2108-55-6